U.K. pharmaceutical giant GSK said the deal gives it the rights to develop, manufacture and commercialize messenger RNA-based candidate vaccines for flu and COVID-19.
NeuroSense Therapeutics Ltd.’s stock rose 6.5% Tuesday, as analysts cheered data from the biotech’s late-stage trial of a treatment for the fatal disease amyotrophic lateral sclerosis, or ALS.
Southwest Airlines Co. said Wednesday its board is adopting a limited-duration shareholder rights plan that is effective immediately and will expire in one year.